GLUTARALDEHYDE SODIUM BISULFITE ADDITION COMPOUND, 95%
- CAS NO.：7420-89-5
- Empirical Formula: C5H13NaO8S2
- Molecular Weight: 288.26
- MDL number: MFCD00078401
- EINECS: 231-043-5
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-01-13 11:19:10
What is GLUTARALDEHYDE SODIUM BISULFITE ADDITION COMPOUND, 95%?
Chemical properties
white to almost white powder
The Uses of GLUTARALDEHYDE SODIUM BISULFITE ADDITION COMPOUND, 95%
Glutaraldehyde may be used as a cross-linking reagent.
Properties of GLUTARALDEHYDE SODIUM BISULFITE ADDITION COMPOUND, 95%
| Melting point: | >300 °C (lit.) |
| Density | 1.822 at 20℃ |
| vapor pressure | 0Pa at 25℃ |
| storage temp. | Store below +30°C. |
| solubility | 1 M NaOH: soluble50mg/mL, clear (colourless to dark yellow-orange) |
| form | Solid:particulate/powder |
| PH | 3-5 (100g/l, H2O, 20℃) |
| EPA Substance Registry System | Glutaraldehyde bis(sodium bisulfite) (7420-89-5) |
Safety information for GLUTARALDEHYDE SODIUM BISULFITE ADDITION COMPOUND, 95%
Computed Descriptors for GLUTARALDEHYDE SODIUM BISULFITE ADDITION COMPOUND, 95%
New Products
Paroxetine Impurity G/Paroxetine Related Compound E 1-Aminocyclopentane carbonitrile (RS)-beta-Amino-beta-(4-bromophenyl)propionic acid N,N CARBONYL DIIMIDAZOLE 2-Amino-5-bromo-4-(trifluoromethyl)pyridine（RM for Indian lab) Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate (R)-1-Benzyl-3-pyrrolidinecarbonitrile Betahistine EP Impurity C Cyclobenzaprine N-oxide/Citalopram Related Compound E Chlorthalidone Impurity I Carbamazepine EP Impurity G Sumatriptan Succinate USP Related Compound C 2,2'-(5-methyl-1,3-phenylene)-di(2-Methylpropionitrile) 4-Fluorothiophenol 1-methyl amino-2,4-dinitro benzene 5-Methyl-1,3-benzenediacetonitrile (R)-BoroLeu-(+)-Pinanediol-CF3COOH 4-(5-amino-1-methyl-1h-benzoimidazol-2-yl)-butyric acid isopropyl ester. 4-Bromo Benzylcyanide 3-Hydroxypropionitrile 3,4 Dimethoxy Benzylcyanide valeronitrile 3-chlorobenzyl cyanide 2-Chloro BenzylcyanideRelated products of tetrahydrofuran
You may like
-
2847776-12-7 Sumatriptan Succinate USP Related Compound C NLT 95%View Details
2847776-12-7 -
1012886-75-7(HCl Salt)/69675-10-1(Freebase) Paroxetine Impurity G/Paroxetine Related Compound E NLT 95%View Details
1012886-75-7(HCl Salt)/69675-10-1(Freebase) -
2856-63-5 99%View Details
2856-63-5 -
3,4 Diethoxy Benzylcyanide 99%View Details
27472-21-5 -
Bromoacetaldehyde Dimethyl Acetal (stabilized with K2CO3)View Details
7252-83-7 -
157528-56-8 (R)-1-Benzyl-3-pyrrolidinecarbonitrile 98+View Details
157528-56-8 -
157528-56-8 (R)-1-Benzyl-3-pyrrolidinecarbonitrile 98+View Details
157528-56-8 -
5-azidovalericacidView Details
79583-98-5
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.